^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JD023

    i
    Other names: JD023, Allogenic CD123-CAR-NK Cells, CD123-CAR-NK
    Associations

    News

    Trials
    Company:
    Beijing JD Biotech
    Drug class:
    NK cell stimulant, CD123 inhibitor
    Related drugs:
    Associations

    News

    Trials
    11ms
    Off-the-shelf CD123 CAR-NK for R/R AML (clinicaltrials.gov)
    P1, N=12, Recruiting, Peking University People's Hospital
    New P1 trial
    |
    JD023
    2years
    Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia (clinicaltrials.gov)
    P1, N=12, Recruiting, Affiliated Hospital to Academy of Military Medical Sciences | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CD123 (Interleukin 3 Receptor Subunit Alpha)
    |
    CD123 positive
    |
    JD023
    2years
    Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia (clinicaltrials.gov)
    P1, N=12, Not yet recruiting, Affiliated Hospital to Academy of Military Medical Sciences
    New P1 trial
    |
    CD123 (Interleukin 3 Receptor Subunit Alpha)
    |
    CD123 positive
    |
    JD023